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Abstract
Molecule optimization is a fundamental task for accelerating drug dis-
covery, with the goal of generating new valid molecules that maximize
multiple drug properties while maintaining similarity to the input molecule.
Existing generative models and reinforcement learning approaches made
initial success, but still face difficulties in simultaneously optimizing mul-
tiple drug properties. To address such challenges, we propose the MultI-
constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework
to use input molecule as an initial guess and sample molecules from the tar-
get distribution. MIMOSA first pretrains two property-agnostic graph neural
networks (GNNs) for molecule topology and substructure-type prediction,
where a substructure can be either atom or single ring. For each iteration,
MIMOSA uses the GNNs’ prediction and employs three basic substructure
operations (add, replace, delete) to generate new molecules and associated
weights. The weights can encode multiple constraints including similarity
and drug property constraints, upon which we select promising molecules
for next iteration. MIMOSA enables flexible encoding of multiple property-
and similarity-constraints and can efficiently generate new molecules that
satisfy various property constraints and achieved up to 49.6% relative
improvement over the best baseline in terms of success rate.
1 Introduction
Designing molecules with desirable properties is a fundamental task in drug
discovery. Traditional methods such as high throughput screening (HTS) tests
large compound libraries to identify molecules with desirable properties, which
are inefficient and costly [25, 33]. Two important machine learning tasks have
been studied in this context:
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• Molecule generation aims at creating new and diverse molecule graphs
with some desirable properties [14, 32];
• Molecule optimization takes a more targeted approach to find molecule
Y with improved drug properties such as drug likeness and biological
activity given an input molecule X [17, 34, 9].
Existing works on molecule optimization and molecule generation tasks
can be categorized as generative models [18, 7, 12] and reinforcement learning
(RL) methods [32, 34]. Most existing works only optimize a single property,
while multiple properties need to be optimized in order to develop viable drug
candidates. Recently, [16] proposed a molecule generation algorithm that can
optimize multiple properties which is a related but different task than molecule
optimization since they do not take any specific input molecule as the anchor.
[23] proposed a genetic algorithm (GA) for molecule generation and optimization.
In this work, we propose a sampling based strategy to tackle the molecule
optimization for multi-properties.
To allow for flexible and efficient molecule optimization on multiple properties,
we propose a new sampling based molecule optimization framework named MultI-
constraint MOlecule SAmpling (MIMOSA). MIMOSA uses the input molecule as an
initial guess and pretrains two graph neural networks (GNNs) on molecule topol-
ogy and substructure-type predictions to produce better molecule embedding for
sampling, where substructure can be either an atom or a ring. In each iteration,
MIMOSA uses the prediction and employs three basic substructure operations (add,
replace, delete) to generate new molecule candidates and associated weights.
The weights thus effectively encode multiple constraints including similarity to
the input molecule and various drug properties, upon which we accept promising
molecules for next iteration sampling. MIMOSA iteratively produces new molecule
candidates and can efficiently draw molecules that satisfy all constraints. The
main contributions of our paper are listed below.
• A new sampling framework for flexible encoding of multiple con-
straints. We reformulate molecule optimization task in a sampling frame-
work to draw molecules from the target distribution (Eq. (1)). The frame-
work provides flexible and efficient encoding of multi-property and similarity
constraints as a target distribution (Section 3.1).
• Efficient sampling augmented by GNN pretraining. With the help
of two pretrained GNN models, we designed a Markov Chain Monte Carlo
(MCMC) based molecule sampling method that enables efficient sampling
from a target distribution (Section 3.2). This enables MIMOSA to leverage
vast amount molecule data in an unsupervised manner without the need of
any knowledge of molecule pairs (i.e., an input molecule and an enhanced
molecule) as many existing methods do.
• Guaranteed unbiased sampling. We provide theoretical analysis to
show that the proposed MCMC method draws unbiased samples from the
target distribution, i.e., exhibiting ergodicity and convergence (Section 3.3).
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We compare MIMOSA with state-of-the-art baselines on optimizing several im-
portant properties across multiple settings, MIMOSA achieves 43.7% success rate
(49.6% relative improvement over the best baseline GA [23]) when optimizing
DRD and PLogP jointly.
2 Related Work
Generative models for molecule optimization project an input molecule
to a latent space, then search in the latent space for new and better molecules.
For example, [12], [3] utilized SMILES strings as molecule representations to
generate molecules. Since string-based approaches often create many invalid
molecules, [18] and [7] designed grammar constraints to improve the chemical
validity. Recently, [23] proposed to explore molecule generation using a genetic
algorithm. Another line of works focus on graph representations of molecules,
e.g., MolGAN [5], CGVAE (Constrained Graph VAE) [22], JTVAE (Junction
Tree VAE) based approaches [14, 17, 15]. Although almost perfect on generating
valid molecules, most of them rely on paired data as training data.
Reinforcement learning for molecule optimization are also developed on
top of molecule generators for achieving desirable properties. For example, [24],
[28], [26] applied RL techniques on top of a string generator to generate SMILES
strings. They struggled with validity of the generated chemical structures.
Recently, [32], [34] leverage deep reinforcement learning to generate molecular
graph, achieving perfect validity. However, all these methods require pre-training
on a specific dataset, which makes their exploration ability limited by the
biases present in the training data. More recently, [16] focused on molecule
generation method for creating molecules with multiple properties. However, this
approach can lead to arbitrary diverse structures (not optimized for a specific
input molecule) and assumes each property is associated with specific molecular
substructures which are not applicable to all properties.
In this paper, we proposed a new molecule optimization method that casts
molecule optimization as a sampling problem, which provides an efficient and
flexible framework for optimizing multiple constraints (e.g., similarity constraint,
multiple property constraints) simultaneously.
3 The MIMOSA Method
3.1 Molecule Optimization via Sampling
Slightly different from general molecule generation that focuses on generating
valid and diverse molecules, the molecule optimization task takes a molecule X
as input, and aims to obtain a new molecule Y that os not only similar to X
but also have more desirable drug properties than X.
We formulate a Markov Chain Monte Carlo (MCMC) based sampling strategy.
The MCMC methods are popular Bayesian sampling approaches of estimating
posterior distributions. They allow drawing samples from complex distributions
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with desirable sampling efficiency [31] as long as unnormalized probability density
for samples can be calculated.
Here to formulate molecule optimization that aim to optimize on similarity
between the input molecule X and the target molecules Y as well as M molecular
properties of Y , P1, · · · ,PM (the higher score the better). We propose to draw
Y from the unnormalized target distribution in Eq. (1).
pX(Y ) ∝ 1(Y ) exp
(
η0sim(X,Y ) + η1
(
P1(Y )− P1(X)
)
+ · · ·+ ηM
(
PM (Y )− PM (X)
)) (1)
where η0, η1, · · · , ηM ∈ R+ are the hyperparameters that control the strength of
various terms, 1(Y ) is an indicator function measuring whether the molecule Y
is a valid molecule. It is added to ensure the validity of the generated molecule Y .
The target distribution is designed to encode any number of type of constraints,
including similarity constraint and multiple drug property constraints. Here the
use of exp is to guarantee pX(Y ) is valid probability distribution. Usually we
define the similarity sim(X,Y ) as in Def. 1 and measured using Eq. (2).
Definition 1 (Tanimoto Similarity of Molecules). Denote SX and SY as
fragment descriptor1 sets of molecule X and Y , respectively. The Tanimoto
similarity between X and Y is given by
sim(X,Y ) =
|SX ∩ SY |
|SX ∪ SY | ∈ [0, 1], (2)
where ∩,∪ represent the intersection and union of two binary vectors respectively;
| · | denotes the cardinality of a set. Higher value means more similar.
3.2 The MIMOSA Method for Molecule Sampling
Fig. 1 illustrates the overall procedure of MIMOSA, which can be decomposed
into the following steps: (1) Pretrain GNN. MIMOSA pre-trains two graph neural
networks (GNNs) using a large number of unlabeled molecules, which will be
used in the sampling process. Then MIMOSA iterates over the following two
steps. (2) Candidate Generation. We generate and score molecule candidates
via modification operations (add, delete, replace) to the current molecule. (3)
Candidate Selection. We perform MCMC sampling to select promising molecule
candidates for the next sampling iteration by repeating Step 2 and 3. Note that
all modification operations are on the substructure level, where a substructure
can be either an atom or a single ring. The substructure set includes all 118
atoms and 31 single rings.
1Fragment descriptors, represent selected substructures (fragments) of 2D molecular graphs
and their occurrences in molecules; they constitute one of the most important types of molecular
descriptors [1].
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Table 1: Notations used in the paper.
Notations short explanation
X, Y Input molecule, target molecule.
sim(X,Y ) ∈ [0, 1] Similarity of molecules X and Y .
pX(Y ) Target dist. when optimizing X, Eq. 1.
M # of properties to optimize.
γ0, γ1, · · · , γM ∈ R+ Hyperparameter in Target dist. pX(Y ).
P1, · · · ,PM Molecular properties to optimize.
1(Y ) Validity Indicator func. of molecule Y .
K Depth of GNN.
h
(k)
v ∈ R300 Node embedding v in the k-th layer.
C1/C2 # of all possible substructures/bonds.
v; sv/s
′
v node v; substructures of v.
fv/ge one-hot node/edge feature.
yˆv/mGNN(Y, v) substructure distribution. Eq. (6).
zˆv/bGNN(Y, v) probability of v will expand. Eq. (9).
yv/zv ground truth label of node v
Y/Y ′ current/next Sample.
Sadd, Sreplace, Sdelete sampling operation from Y to Y
′.
(I) Pretrain GNNs for Substructure-type and Molecule Topol-
ogy Prediction
To provide accurate molecule representation, we propose to pretrain molecule
embeddings on large molecule datasets. Since we consider molecules in graph
representations where each substructure is a node, we develop two GNN based
pretraining tasks to assist molecule modification. These two GNNs will assess
the probability of each substructure conditioned on all the other substructures
in the molecule graph.
Mathematically, in molecular graph Y = (V,E), we have one-hot node feature
fv ∈ {0, 1}C1 for every node v ∈ V and one-hot edge feature ge ∈ {0, 1}C2 for
every edge e = (u, v) ∈ E. C1 and C2 are the number of substructures and the
number of bond types, respectively. In our experiment, C1 = 149, including 118
atoms, 31 single rings, and C2 = 4 correspond to the four bond types. We list
the node and edge features in the appendix.
The two Graph Neural Networks (GNN) [13] are learned with these node
and edge features and the same molecule graph to learn an embedding vector
hv for every node v ∈ V .
h(k)v =ReLU
(
MLP
(
CONCAT
( ∑
u∈N (v)∪{v}
h(k−1)u ,
∑
e=(u,v):u∈N (v)
g(k−1)e
)))
,
(3)
where the layer k = 1, · · · ,K; CONCAT(·, ·) is the concatenation of two vectors;
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Figure 1: The Multi-constraint Molecule Sampling for Molecule Optimiza-
tion(MIMOSA) framework illustrated using a single molecule. In Step I (Pretrain
GNN), MIMOSA pretrains two property-agnostic GNNs for molecule topology and
substructure-type prediction. Then, in Step II (Candidate Generation), MIMOSA
uses the prediction and employs three basic substructure operations (ADD,
REPLACE and DELETE) to generate new molecule candidates. In Step III
(Candidate Selection), MIMOSA assigns weights for new molecule. The weights can
encode multiple constraints including similarity and drug property constraints,
upon which we accept promising molecules for next iteration. MIMOSA iteratively
edits the molecule and can efficiently draw molecule samples.
N (v) is the set of all neighbors of v; h(0)v is the initial node embedding fv. After
K layers of GNN, we have the final node embedding h
(K)
v for node v. In our
experiment, K = 5.
Using the same GNN architecture, we trained two GNN models: one for
substructure-type prediction called mGNN and one for molecule topology pre-
diction called bGNN: We choose to train two separate GNNs instead of sharing
a single GNN because sufficient unlabeled molecule samples exist and the two
tasks are very different in nature.
The mGNN model aims at multi-class classification for predicting the
substructure type of a masked node. The mGNN model outputs the type of
an individual substructure conditioned on all other substructures and their
connections. We mask the individual substructure, replace it with a special
masked indicator following [13]. Suppose we only mask one substructure for each
molecule during training and v is the masked substructure (i.e., node), yv is the
node label corresponding to masked substructure type, we add fully-connected
(FC) layers with softmax activation (Eq. (4)) to predict the type of the node v.
yˆv = Softmax
(
FC(h(K)v )
)
. (4)
where yˆv is a C1 dimension vector, indicating the predicted probability of all
possible substructures. Multi-class cross entropy loss (Eq. (5)) is used to guide
the training of GNN:
L(yv, yˆv) = −
C1∑
i=1
(
(yv)i log(yˆv)i
)
, (5)
where yv is the groundtruth, one-hot vector. C1 is number of all substructures
(atoms and single rings), (yv)i is i-th element of vector yv.
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To summarize, the prediction of mGNN is defined as
yˆv , mGNN(Y,mask = v) = mGNN(Y, v), (6)
where in a given molecule Y the node v is masked, mGNN predicts the substruc-
ture distribution on masked node v, which is denoted yˆv.
The bGNN model aims at binary classification for predicting the molecule
topology. The goal of bGNN is to predict whether a node will expand. To
provide training labels for bGNN, we set the leaf nodes (nodes with degree 1)
with label zv = 0 as we assume they are no longer expanding. And we set label
zv = 1 on the non-leaf nodes that are adjacent to leaf nodes as those nodes
expanded (to the leaf nodes). The prediction is done via
zˆv = Sigmoid
(
FC(h(K)v )
)
, (7)
where FC is two-layer fully-connected layers (of 50 neurons followed by 1 neuron).
h
(K)
v is defined in Eq. (3), the node embedding of v produced by GNN. Binary
cross-entropy loss is used to guide the training:
L(zv, zˆv) = −zv log(zˆv)− (1− zv) log(1− zˆv). (8)
Since the total number of unlabeled molecules is large, when training bGNN we
randomly select one substructure v for each molecule to speed up the pretraining.
In sum, prediction of bGNN is defined as
zˆv , bGNN(Y, v), (9)
where v is a node in molecule Y , zˆv is the probability that v will expand.
(II) Candidate Generation via Substructure Modification
Operation
With the help of mGNN and bGNN, we define substructure modification opera-
tions namely replace, add or delete on input molecule Y :
• Replace a substructure. At node v, the original substructure category is sv.
1. We mask v in Y , evaluate the substructure distribution in v via mGNN,
i.e., yˆv = mGNN(Y, v), as Eq. (6).
2. Then we sample a new substructure s′v from the multinomial distribution
yˆv, denoted by s
′
v ∼ Multinomial(yˆv).
3. At node v, we replace the original substructure sv with new substructure
s′v to produce the new molecule Y
′.
The whole operation is denoted as
Y ′ ∼ Sreplace(Y ′|Y ). (10)
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• Add a substructure. Suppose we want to add a substructure as leaf node
(denoted as v) connecting to an existing node u in current molecule Y . The
substructure category of v is denoted sv, which we want to predict.
1. We evaluate the probability that node u has a leaf node v with help of
bGNN in Eq. (9), i.e.,
zˆu = bGNN(Y, u) ∈ [0, 1].
2. Suppose the above prediction is to add a leaf node v. We then generate
a new molecule Y ′ via adding v to Y via a new edge (u, v).
3. In Y ′, sv, the substructure of v is unknown. We will predict its substruc-
ture using mGNN, i.e., yˆv = mGNN(Y
′, v), following Eq. (6).
4. We sample a new substructure s′v from the multinomial distribution yˆv
and complete the new molecule Y ′.
The whole operation is denoted as
Y ′ ∼ Sadd(Y ′|Y ). (11)
• Delete a substructure. We delete a leaf node v in current molecule Y . It is
denoted
Y ′ ∼ Sdelete(Y ′|Y ). (12)
In the MCMC process, S∗(Y ′|Y ) indicates the sequential sampling process
from previous sample Y to next sample Y ′. And the very first sample is the
input X.
Handling Bond Types and Rings. Since the number of possible bonds are small
(single, double, triple, aromatic), we enumerate all and choose the one with
largest pX(Y ). In some case, basic operation would generate invalid molecules.
Based on the indicator function in target distribution in Eq. (1), the density is
equal to 0. Thus, we perform validity check using RDKit [19] to filter out the
new molecule graphs that are not valid. When adding/replacing a ring, there
might be multiple choices to connect to its neighbor. We enumerate all possible
choices and retain all valid molecules.
(III) Candidate Selection via MCMC Sampling
The set of generated candidate molecules can be grouped as three sets based on
the type of substructure modification they received, namely, replace set Sreplace,
add set Sadd, and delete set Sdelete. MIMOSA uses the Gibbs sampling [10], a
particular type of MCMC, for molecule candidate selection. Gibbs sampling
algorithm generates an instance from the distribution of each variable in se-
quential or random order [20], conditional on the current values of the other
variables. Here molecules from the three sets will be sampled with different
sampling weights. Their weights are designed to satisfy the detailed balance
8
condition [4].
Sampling Sreplace. For molecules produced by the “replace” operation, the weight
in sampling wr is given by Eq. (13).
wr =
pX(Y
′) · [mGNN(Y, v)]s′v
pX(Y ) · [mGNN(Y, v)]sv
, (13)
where PX(·) is the unnormalized target distribution for optimizing X, defined in
Eq. (1), [mGNN(Y, v)]sv is the predicted probability of the substructure sv in
the prediction distribution mGNN(Y, v). The acceptance rate in the proposal is
min{1, wr}. If the proposal is accepted, we use the new prediction s′v to replace
origin substructure sv in current molecule Y and produce the new molecule Y
′.
Sampling Sadd. For molecules produced by the “add” operation, the weight in
sampling is given by Eq. (14).
wa =
pX(Y
′) · bGNN(Y, u) · [mGNN(Y ′, v)]sv
pX(Y ) · (1− bGNN(Y, u)) , (14)
where The acceptance rate in the proposal is min{1, wa}.
Sampling Sdelete. For these molecules produced by “delete” operation, the weight
in sampling is given by Eq. (15).
wd =
pX(Y
′) · (1− bGNN(Y ′, u))
pX(Y ) · bGNN(Y ′, u) · [mGNN(Y, v)]sv
, (15)
where v is the deleted node, leaf node (with degree 1) in molecular graph of Y .
u and v are connected in Y . The acceptance rate in the proposal is min{1, wd}.
Soft-constraint Encoding. For these operations, any number or type of constraints
(e.g., here the similarity and drug property constraints) can be encoded in pX(Y )
and pX(Y
′) and thus reflected in the weights wr, wa, wd.
For a single-chain MCMC, we construct the transition kernel as given by
Eq. (16).
Y ′ ∼

Sreplace(Y
′| Y ), prob γ1, accept w. min{1, wr},
Sadd(Y
′| Y ), prob. γ2, accept w. min{1, wa},
Sdelete(Y
′| Y ), prob. γ3, accept w. min{1, wd},
(16)
where γ1, γ2, γ3 ∈ R+ are hyperparameters that determine the sampling prob-
abilities from the three molecule sets. In Section 3.3, we show the transition
kernel will leave the target distribution pX(Y ) invariant for arbitrary γ1, γ2, γ3
satisfying γ1 + γ2 + γ3 = 1 and γ2 = γ3. After molecules are sampled, they
will be accepted with their corresponding acceptance probabilities related to
wr, wa, wd.
The MIMOSA method is summarized in Algorithm 1. To accelerate the sampling
procedure, we also deploy a multi-chain strategy [21]: during each step, we use
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Algorithm 1 MIMOSA for Molecule Optimization
1: Input: molecule X, # of Particle N , max # of sampling iter. Tmax, # of
burn-in iter. Tburnin
2: Output: Generated molecules Φ.
3: # Step (I) Pretrain GNN
4: Train mGNN (Eq.6), bGNN (Eq.9).
5: Candidate set Θ = {X}, Output set Φ = {}.
6: for iter = 1, · · · , Tmax do
7: # Step (II) Candidate Generation.
8: Candidate Pool Ψ = {}.
9: for molecule Z in Θ do
10: Generate candidates Z ′ via editing Z using substructure operations;
validity check; add Z ′ in Ψ.
11: end for
12: Θ = {}.
13: # Step (III) Candidate Selection.
14: if iter < Tburnin then
15: Select N molecules with highest density value (Eq. 1) from Ψ and add
them into Θ.
16: else
17: Draw N molecules from Ψ using importance sampling (∝ weight wr in
Eq. (13), wa in Eq. (14) or wd in Eq. (15)) and add to Θ.
18: end if
19: Φ = Φ ∪Θ.
20: end for
N samples for each state, with each sample generating multiple proposals. Also,
during burn-in period (Step 12 in Algorithm 1), we pick the molecules with
highest density for efficiency [4]. We retain N proposals in iterative sampling.
3.3 Analysis of the MCMC Algorithm
Our MCMC method draws unbiased samples from the target distribution, i.e.,
exhibiting ergodicity and convergence. We defer the proofs of Lemma 1 and 2
to the appendix.
Theorem 1. Suppose {Y1, Y2, · · · , Yn} is the chain of molecules sampled via
MCMC based on transition kernel defined in Eq. (16), with initial state X, then
the Markov chain is ergodic with stationary distribution pX(Y ) in Eq. (1). That
is, empirical estimate (time average over Y1, Y2, · · · , Yn) is equal to target value
(space average over pX(Y )), i.e., lim
n−→+∞
1
n
∑n
i=1 f(Yi) =
∫
f(Y )pX(Y )dY holds
for any integratable function f .
Proof Sketch. We split the proof into Lemma 1 and 2. First, regarding the
ergodicity, it is sufficient to prove the irreducibility, aperiodicity of the Markov
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chain (Lemma 1). Then, to show that pX(Y ) is maintained invariant for the
whole chain, in Lemma 2, we show that detailed balance condition holds for
any neighboring samples (Yi and Yi+1). Then we strengthen this results on the
whole chain.
Lemma 1. The Markov chain of the sampled molecules ({Y1, · · · , Yn}, starting
at X, based on transition kernel in Eq. (16)) is ergodic over the target distribution
pX(Y ).
Lemma 2. pX(Y ) is maintained as the invariant distribution for the whole
Markov chain produced by MCMC transition kernel defined in Eq. (16).
4 Experiment
4.1 Experimental Setup
Dataset and Molecular Properties. We use 2 million molecules from ZINC
database [30, 13] to train both mGNN and bGNN. Following [32, 17, 34, 15, 9],
we focus on the molecular properties below. For all scores, the higher the better.
• QED (Quantitative Estimate of Drug likeness) is an indicator of drug-likeness [2].
• DRD (Dopamine Receptor) measures a molecule’s biological activity against
a biological target dopamine type 2 receptor [6].
• PLogP (Penalized LogP) is the log of the partition ratio of the solute between
octanol and water minus the synthetic accessibility score and number of long
cycles [8].
Note that PLogP is more sensitive to the change of local molecule structures,
while DRD and QED are related to both local and global molecule structures. For
chemically valid molecules, their QED, DRD2 and LogP scores can be evaluated
using the RDkit package [19].
Baseline Methods. We compare MIMOSA with the following molecule optimiza-
tion baselines. The parameter setting of these methods are provided in the
appendix.
• JTVAE (Junction Tree Variational Auto-Encoder) [14] is a generative model
that learns latent space to generate desired molecule. It also uses an encoder-
decoder architecture and leverage a junction tree to simplify molecule genera-
tion procedure.
• VJTNN (Variational Junction Tree Encoder-Decoder) [17] improves over
JTVAE by leveraging adversarial learning and attention.
• GCPN (Graph Convolutional Policy Network) [32]. GCPN is state-of-the-art
reinforcement learning based approach on molecule optimization. It leverages
graph convolutional policy networks to generate molecular structures with
specific property, where molecular property is included in reward.
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• GA (Genetic Algorithm) [23] is a genetic algorithm that explores chemical
space efficiently.
Details on Implementation, Features, Dataset Construction, Evalua-
tion Strategies are in Appendix.
Metrics We consider the following metrics for evaluation.
• Similarity between the input and generated molecule, measured by Tanimoto
similarity over Morgan fingerprints [29], defined in Eq. (2).
• Property Improvement of generated molecule in QED, DRD, and PLogP. It
is defined as the difference of the property score between generated molecules
Y and input molecule X, i.e., property(Y )− property(X).
• Success Rate (SR) based on similarity and property improvement between
input molecule X and generated molecule Y . We follow the same definitions
of SR as in [17] (See details in appendix).
4.2 Results
Exp 1. Optimize Multiple Properties
To evaluate model performance on optimizing multiple drug properties, we
consider the following combinations of property constraints:
(1) optimize QED (drug likeness) and PLogP (solubility);
(2) optimize DRD (biological activity against dopamine type 2 receptor ) and
PLogP (solubility).
Table 2: Exp 1. Optimizing Multiple Properties.
Optimizing PLogP and QED
Method Similarity PLogP-Imp. QED-Imp. Success
JTVAE 0.16±0.08 0.14±0.27 0.01±0.10 0.4%
VJTNN 0.17±0.06 0.46±0.35 0.02±0.09 1.0%
GCPN 0.25±0.15 0.56±0.25 0.06±0.08 11.3%
GA 0.35±0.16 0.93±0.67 0.09±0.07 24.9%
MIMOSA 0.42±0.17 0.93±0.48 0.10±0.09 32.0%
Optimizing PLogP and DRD
Method Similarity PLogP-Imp. DRD-Imp. Success
JTVAE 0.18±0.08 0.20±0.18 0.18±0.09 0.8%
VJTNN 0.18±0.08 0.55±0.16 0.27±0.05 3.4%
GCPN 0.23±0.12 0.38±0.25 0.25±0.11 20.4%
GA 0.38±0.16 0.68±0.49 0.20±0.16 29.3%
MIMOSA 0.54±0.16 0.75±0.48 0.35±0.20 43.7%
From Table 2, MIMOSA has significantly better and stable performance on
all metrics, with 28.5% relative higher success rate in optimizing both QED
and PLogP, and 49.6% relative higher success rate in optimizing both DRD
and PLogP compared with the second best algorithm GA. The GA algorithm
12
(a) Input
Molecule X;
QED:0.72;
PLogP:-3.60
(b) sim: 0.66;
QED: 0.93;
PLogP: -1.2
(c) sim: 0.59;
QED: 0.93;
PLogP: -1.1
(d) sim: 0.57;
QED: 0.92;
PLogP:-1.6
(e) Input
Molecule X;
QED: 0.71;
PLogP: -3.9
(f) sim: 0.837;
QED: 0.90;
PLogP: -0.6
(g) sim: 0.872;
QED: 0.89;
PLogP: -1.2
(h) sim: 0.812;
QED: 0.88;
PLogP: -1.4
Figure 2: Exp 3. Examples of “QED & PLogP” optimization. (Upper), the
imidazole ring in the input molecule (a) is replaced by less polar rings thiazole
(b and c) and thiadiazol (d). Since more polar indicates lower PLogP, the output
molecules increase PLogP while maintaining the molecular scaffold. Lower),
the PLogP of input molecule (e) is increased by neutralizing the ionized amine
(g) or replacing with substructures with less electronegativity (f and h). These
changes improve the QED.
uses genetic algorithm for local structure editing, hence is expected to work well
on optimizing properties that are sensitive to local structural changes, such as
joint optimizing both QED and PLogP where PLogP is related to the polarity
of a molecule and is sensitive to the change of local structure. Because of the
local editing of GA, GA does not perform well on optimizing both DRD and
PLogP since DRD is less sensitive to the change of local structures. Among
other baselines, GCPN has better performance. However, its performance is not
stable when optimizing PLogP and QED simultaneously, since it can generate
molecules with negative QED improvement.
Exp 2. Optimize Single Property
Since most baseline models were designed to optimize single drug properties,
we also conduct experiments to compare MIMOSA with them on optimizing the
following single properties: (1) DRD; (2) QED and (3) PLogP.
From the results shown in Table 3, we can see that when optimizing a single
drug property, MIMOSA still achieved the best performance overall, with 17.2%
relative higher success rate in optimizing QED compared with the second best
model GA, and 18.3% relative higher success rate in optimizing both DRD
compared with the second best algorithm VJTNN. Among the baseline models,
algorithms such as JTVAE, VJTNN, and GCPN that were designed to optimize
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Table 3: Exp 2. Optimizing Single Property.
Optimizing QED
Method Similarity QED-Improve Success
JTVAE 0.30±0.09 0.17±0.12 17.4%
VJTNN 0.37±0.11 0.20±0.05 37.6%
GCPN 0.32±0.14 0.20±0.09 26.5%
GA 0.43±0.17 0.17±0.11 42.5%
MIMOSA 0.50±0.30 0.20±0.14 47.8%
Optimizing DRD
Method Similarity DRD-Improve Success
JTVAE 0.31±0.07 0.34±0.17 25.6%
VJTNN 0.36±0.09 0.40±0.20 40.5%
GCPN 0.30±0.07 0.35±0.20 27.8%
GA 0.46±0.14 0.25±0.10 37.5%
MIMOSA 0.57±0.29 0.43±0.29 48.3%
Optimizing PLogP
Method Similarity PLogP-Improve Success
JTVAE 0.30±0.09 0.28±0.17 2.9%
VJTNN 0.38± 0.08 0.47±0.24 14.3%
GCPN 0.32± 0.07 0.33±0.19 7.8%
GA 0.53±0.15 0.99±0.54 92.8%
MIMOSA 0.56± 0.17 0.94±0.47 94.0%
single property have good performance in property improvement as expected,
however they generate molecules that have lower similarity hence the final success
rates. Also, GA has the lowest QED and DRD improvement maybe due to its
limitation in capturing global properties. High similarity between the output
and input molecules is a unique requirement for the molecule optimization task,
on which MIMOSA significantly outperformed the other baselines.
Exp 3. Case Study: Properties that are sensitive to local
structural changes
To further examine how MIMOSA can also effectively improve properties that are
sensitive to local structural change, e.g., PLogP, we show two examples in Fig. 2.
For the first row, the imidazole ring in the input molecule (a) is replaced by less
polar five-member rings thiazole (b and c) and thiadiazol (d). Since PLogP is
related to the polarity of a molecule: more polar indicates lower PLogP. The gen-
eration results in the increase of PLogP while maintaining the molecular scaffold.
For the second row, the PLogP of input molecule (e) is increased by neutralizing
the ionized amine (g) or replacing with substructures with less electronegativity (f
and h). These changes would also help improve the drug likeness, i.e., QED value.
Sampling Efficiency. The sampling complexity is O(NN2) where N the size
14
of candidate set (e.g., 20) and N2 is the size of the possible proposal set (< 200).
Empirically, this entire sampling process takes about 10-20 minutes for optimizing
one source molecule, which is very acceptable for molecule optimization. And
MCMC can directly operate with an unnormalized distribution which is more
efficient. Note that all the existing methods for molecule optimization also
utilize RDKit in their learning process, either in preprocessing steps for creating
training data [14, 17], or inside their training procedure such as using RDKit to
evaluate reward for reinforcement learning [32, 27, 34].
5 Conclusion
In this paper, we proposed MIMOSA, a new MCMC sampling based method
for molecule optimization. MIMOSA pretrains GNNs and employs three basic
substructure operations to generate new molecules and associated weights that
can encode multiple drug property constraints, upon which we accept promising
molecules for next iteration. MIMOSA iteratively produces new molecule candidates
and can efficiently draw molecules that satisfy all constraints. MIMOSA significantly
outperformed several state of the arts baselines for molecule optimization with
28.5% to 49.6% improvement when optimizing PLogP+QED, and PLogP+DRD,
respectively.
Appendix
Proof of Lemma 1.
Proof. For a Markov chain, to guarantee its ergodicity, it is sufficient to prove
its irreducibility and aperiodicity [11].
Regarding irreducibility, without loss of generalization, we need to prove
that any molecule pairs (Y , Z) can communicate with each other, i.e., Y ↔ Z.
Both Y and Z are states of the Markov chain.
First, we want to show Y −→ Z, i.e., the state Y is accessible from state Z.
This boils down to prove ∃ n ∈ N such that PnY,Z > 0. To show this, we construct
such a Markov chain {Y0, Y1, · · · , Yn}, where Y0 = Y and Yn = Z.
First, we apply “delete” operation n1 times to delete substructures of Y until
only one substructure is left, denoted C. That is, we have Yi ∼ Sdelete(Yi|Yi−1) for
i = 1, · · · , n1. Based on acceptance rate defined in Eq. (15), we have P 1Yi−1,Yi > 0
for i = 1, · · · , n1. Y0 = Y, Yn1 = C. We know ∃ n1 ∈ N such that
Pn1Y,C = P
n1
Y0,Yn1
=
n1∏
i=1
P 1Yi−1,Yi > 0.
Given this, we replace the substructure with a single substructure in Z, denoted
as C ′, Yn1+1 ∼ Sreplace(Yn1+1|Yn1). Then starting with C ′ = Yn1+1, we apply
the “add” operation n2 times until we have Z, then Yi ∼ Sadd(Yi|Yi−1) for
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i = n1+2, · · · , n1+n2+1. where Yn1+1 = C ′, Yn1+n2+1 = Z. Based on Eq. (14),
we have P 1Yi−1,Yi > 0 for i = n1 + 2, · · · , n1 + n2 + 1. ∃ n2 ∈ N such that
Pn2C′,Z = P
n2
Yn1+1,Yn1+n2+1
=
n1+n2+1∏
i=n1+2
P 1Yi−1,Yi > 0.
Thus, we have n = (n1+n2) ∈ N s.t. PnY,Z = Pn1+n2+1Y,Z ≥ Pn1Y,C ·P 1C,C′ ·Pn2C,Z > 0.
Similarly, we can show Z −→ Y , i.e., ∃ n ∈ N for PnZ,Y > 0.
Now we have proved Z ↔ Y hold for any molecule pairs (Y, Z). Thus, we
have proved irreducibility.
Next, for aperiodicity, there is a simple test: in Markov chain if there
is a state Y for which the 1-step transition probability p(Y, Y ) > 0, then the
chain is aperiodic [11]. In MIMOSA scenario, the substructure type prediction is
defined in Eq. (6), since it’s softmax output, so for each possible substructure
the probability is bounded away from zero and one. The topology prediction is
defined in Eq. (9), since it’s sigmoid output, the probability is also bounded away
from zero and one. Thus, there exists such a molecule whose the acceptance
probability is lower than 1, i.e., possible to reject the proposal, that is the 1-step
transition probability is greater than 0, so aperiodicity satisfies.
Proof of Lemma 2.
Proof. In MCMC, the detailed balance condition guarantees that p(x)T (x −→
y) = p(y)T (y −→ x), where p(·) is the target distribution for drawing samples,
T (· −→ ·) is the transition kernel from one state to another.
Below we first show for all three proposals detailed balance condition holds
for any neighboring samples (Yi−1 and Yi), then we strengthen this conclusion
on the whole Markov chain.
For “replace” proposal, we have
pX(Y )T (Y −→ Y ′)
=pX(Y ) · [mGNN(Y, v)]sv ·min{1, wr}
=pX(Y ) · [mGNN(Y, v)]sv
·min
{
1,
pX(Y
′) · [mGNN(Y, v)]s′v
pX(Y ) · [mGNN(Y, v)]sv
}
= min
{
pX(Y ) · [mGNN(Y, v)]sv ,
pX(Y
′) · [mGNN(Y, v)]s′v
}
.
(17)
where we focus on replace operation on node v. At node v, sv and s
′
v are the
actual and predicted substructure labels, respectively. wr is defined in Eq. (13).
wr =
pX(Y
′) · [mGNN(Y, v)]s′v
pX(Y ) · [mGNN(Y, v)]sv
, (18)
16
For the other direction, the following equation that shows detailed balance
hold for “replace” proposal.
pX(Y
′)T (Y ′ −→ Y )
=pX(Y
′) · [mGNN(Y, v)]s′v ·min{1, w′r}
=pX(Y
′) · [mGNN(Y, v)]s′v
·min
{
1,
pX(Y ) · [mGNN(Y, v)]sv
pX(Y ′) · [mGNN(Y, v)]s′v
}
= min
{
pX(Y
′) · [mGNN(Y, v)]s′v ,
pX(Y ) · [mGNN(Y ′, v)]sv
}
.
=pX(Y )T (Y −→ Y ′)
(19)
Note that based on definition of mGNN in Eq. (6), during replace operation, we
have
mGNN(Y, v) = mGNN(Y ′, v)
We write mGNN(Y, v) instead of mGNN(Y ′, v) for simplicity.
w′r is the acceptance ratio from Y
′ to Y and satisfy
w′r =
pX(Y ) · [mGNN(Y ′, v)]sv
pX(Y ′) · [mGNN(Y ′, v)]s′v
=
pX(Y ) · [mGNN(Y, v)]sv
pX(Y ′) · [mGNN(Y, v)]s′v
,
For “add” proposal, we have
pX(Y ) · T (Y −→ Y ′)
= pX(Y ) · (1− bGNN(Y, u))) min{1, wa}
= pX(Y ) · (1− bGNN(Y, u))
·min
{
1,
pX(Y
′) · bGNN(Y, u) · [mGNN(Y ′, v)]sv
pX(Y ) · (1− bGNN(Y, u))
}
= min
{
pX(Y ) · (1− bGNN(Y, u)),
pX(Y
′) · bGNN(Y, u) · [mGNN(Y ′, v)]sv
}
(20)
where wa is defined in Eq. (14).
wa =
pX(Y
′) · bGNN(Y, u) · [mGNN(Y ′, v)]sv
pX(Y ) · (1− bGNN(Y, u)) , (21)
For the other direction, the equations below show detailed balance condition
17
holds for “add” proposal.
pX(Y
′) · T (Y ′ −→ Y )
= pX(Y
′) · bGNN(Y, u) · [mGNN(Y ′, v)]sv ·min{1, w′a}
= pX(Y
′) · bGNN(Y, u) · [mGNN(Y ′, v)]sv
·min
{
1,
pX(Y ) · (1− bGNN(Y, u))
pX(Y ′) · bGNN(Y, u) · [mGNN(Y ′, v)]sv
}
= min
{
pX(Y
′) · bGNN(Y, u) · [mGNN(Y ′, v)]sv ,
pX(Y ) · (1− bGNN(Y, u))
}
(22)
where w′a is the acceptance rate from Y
′ to Y using delete operation, defined in
Equation (15).
For the “delete” proposal, we can view it as the reverse procedure of the
“add” proposal, which is easy to prove.
Since detailed balance holds for all proposals, i.e., pX(Yi)T (Yi −→ Yi−1) =
pX(Yi−1)T (Yi−1 −→ Yi), by integrating out Yi−1 on both sides, we obtain
pX(Yi) =
∫
pX(Yi)T (Yi −→ Yi−1)dYi−1
=
∫
pX(Yi−1)T (Yi−1 −→ Yi)dYi−1
(23)
That is, distribution pX(·) is stationary with a transition kernel T (· −→ ·), i.e.,
T (pX) = pX hold for transition kernel that contains “replace”, “add” or “delete”
proposal.
6 More Experimental Details
Implementation We implemented MIMOSA using Pytorch 1.0.1 and Python 3.7
on an Intel Xeon E5-2690 machine with 256G RAM and 8 NVIDIA Pascal Titan
X GPUs. We use Adam optimizer with a learning rate of 0.001. For pretraining,
we follow [13] to set GNNs with 5 layers and 300-d hidden units. For fully
connected layer used in Equation (4) and (7), we use two layer feedforward
NN, the hidden size is 50. Tanimoto similarity, PLogP, and QED scores were
computed using RDKit package [19]. The DRD2 activity prediction model is
publicly available 2. For mGNN, we randomly mask a single node for each
molecule, while for bGNN, we randomly select a leaf node for each molecule.
When training them, we choose batch size 256, epochs number 10, and learning
rate 1e−3, Then, during inference stage, we keep 20 molecules each iteration, i.e.,
in Algorithm 1, N = 20. We set Tmax = 10 and Tburnin = 5. When optimizing
2https://github.com/MarcusOlivecrona/REINVENT
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“QED+PLogP” and “DRD+PLogP” (M = 2), for the target distribution pX(Y )
(defined in Eq. (1)), we have η0 = 1.0, η1 = 0.3, and η2 = 0.3.
Node and Edge Feature
In this paper, a substructure corresponds to a node, which contains 149 different
types, including 118 atoms (e.g., Carbon, Nitrogen, Oxygen, Sulfur, etc) and 31
frequent single rings (e.g., Benzene, Cyclopropane). Each edge corresponds to a
bond in molecular graph. There are totally 4 kinds of bonds, thus we have 4
edge type in total, including single, double, triple and aromatic.
Success Rate For LogP, we define a success as sim(X,Y ) ≥ 0.4 and PLogP(Y )−
PLogP(X) ≥ 0.5. For QED, we define a success as sim(X,Y ) ≥ 0.4 and
QED(Y ) − QED(X) ≥ 0.1. For DRD, we define a success as sim(X,Y ) ≥ 0.4
and DRD(Y ) − DRD(X) ≥ 0.2. For optimizing both QED and PLogP , we
define a success as (i) sim(X,Y ) ≥ 0.3, (ii) QED(Y ) − QED(X) ≥ 0.1, (iii)
PLogP(Y ) − PLogP(X) ≥ 0.3. For optimizing both DRD and PLogP, we
define a success as (i) sim(X,Y ) ≥ 0.3, (ii) DRD(Y ) − DRD(X) ≥ 0.2, (iii)
PLogP(Y )− PLogP(X) ≥ 0.3.
Baseline Setup Below are more detailed about baselines.
JTVAE. We follow [14] to use 780 substructures for junction tree, 5-layers
message passing network as encoder. The hidden state dimension is set to 450.
For the graph encoder, the initial atom features include its atom type, degree,
its formal charge and its chiral configuration. Bond feature is a concatenation
of its bond type, whether the bond is in a ring, and its cis-trans configuration.
For the tree encoder, each cluster is represented with a neural embedding vector.
The tree and graph decoder use the same feature setting as encoders. The graph
encoder and decoder run three iterations of neural message passing. The code is
publicly available from the author website 3. The paired molecules required in
training JTVAE was obtained from from the author website 4.
VJTNN. We follow [17] to set the hidden state dimension as 300 and latent
code dimension as 8. The tree encoder runs message passing for 6 iterations,
and graph encoder runs for 3 iterations. The hidden state dimension of the
recurrent encoder and decoder is set to 600. We leverage the Adam optimizer
for 20 epochs with learning rate 0.001. The learning rate is annealed by 0.9 for
every epoch. For adversarial training, the discriminator has 3-layer and with
hidden layer dimension 300 and LeakyReLU activation function. The code was
obtained from the author website 5.
GCPN. We follow [32] to set up an OpenAI Gym environment using RDKit
package. The maximum atom number is 38. Since we represent molecules in
kekulized form, there are 9 atom types and 3 edge types. We use a 3-layer GCPN
as the policy network with 64 dimensional node embedding in all hidden layers.
3https://github.com/wengong-jin/icml18-jtnn
4https://github.com/wengong-jin/iclr19-graph2graph
5https://github.com/wengong-jin/iclr19-graph2graph
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Batch normalization is applied after each layer. We use Adam optimizer with
batch size 32. The learning rate is set as 0.001. The code was publicly available
the author website 6.
GA. we follow [23] to run each experiment for 20 generations with a population
size of 500. We compute the number of experiments that successfully proposed
molecules with a squared difference less than 1.0. Each run is constrained to run
for 100 generations with a maximum canonical SMILES length of 81 characters.
The code was obtained from the author website7.
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